Cargando…
The use of enoxaparin as bridge to therapeutic INR after LVAD implantation
BACKGROUND: Left ventricular assist devices (LVAD) have been increasingly used in the treatment of end-stage heart failure. While warfarin has been uniformly recommended in the long-term as anticoagulation strategy, no clear recommendation exists for the post-operative period. We sought to evaluate...
Autores principales: | Shah, Zubair, Mastoris, Ioannis, Acharya, Prakash, Rali, Aniket S., Mohammed, Moghni, Farhad, Sami, Ranka, Sagar, Wagner, Savahanna, Zanotti, Giorgio, Salerno, Christopher T., Haglund, Nicholas A., Sauer, Andrew J., Ravichandran, Ashwin K., Abicht, Travis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666514/ https://www.ncbi.nlm.nih.gov/pubmed/33189134 http://dx.doi.org/10.1186/s13019-020-01373-y |
Ejemplares similares
-
Correction to: The use of enoxaparin as bridge to therapeutic INR after LVAD implantation
por: Shah, Zubair, et al.
Publicado: (2021) -
Mechanisms of Myocardial Injury in Coronavirus Disease 2019
por: Rali, Aniket S, et al.
Publicado: (2020) -
Inpatient characteristics, complications, and outcomes of patients with cardiac sarcoidosis: A study from the National Inpatient Sample
por: Taduru, Siva S., et al.
Publicado: (2022) -
Cardiopulmonary Arrest and Extracorporeal Membrane Oxygenation: Case Report and Review
por: Robinson, Alexander, et al.
Publicado: (2018) -
Right Heart Catheterization in Cardiogenic Shock Is Associated With Improved Outcomes: Insights From the Nationwide Readmissions Database
por: Ranka, Sagar, et al.
Publicado: (2021)